Berenberg Downgrades Qiagen Rating, Price Target Amid Rising Competition, Growth Concerns
() -- Berenberg downgraded Qiagen (QIA.F) to hold from buy and reduced its price target to 40 euros from 50 euros, citing growing market pressure on its tuberculosis testing franchise and expectations of a slowdown in US research spending. "Two factors regarding QIAGEN's challenging H1 2026 concern us most. The first i